Rs10887800 Renalase Gene Polymorphism is Associated with an Increased Risk of Coronary Artery Disease in Hemodialyzed Patients

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2016 Mar 30

PMID 27023477

Citations 6

Authors

Anna Stec

Andrzej Ksiazek

Monika Buraczynska

Affiliations

Soon will be listed here.

Abstract

Purpose: Coronary artery disease (CAD) is common in patients with end-stage renal disease (ESRD). Recent studies have suggested that renalase, a novel FAD-dependent amine oxidase, may play an important role in the pathogenesis of cardiovascular complications in ESRD patients. The aim of the study was to investigate the association between renalase gene polymorphisms and a risk of CAD in patients on hemodialysis.

Methods: In a case-control study, a total of 309 hemodialyzed patients (107 with and 202 without CAD) were genotyped for two SNPs in the renalase gene (rs10887800 and rs2576178) using the PCR-RFLP method.

Results: By multivariate logistic regression analysis, we found that rs10887800GG genotype was associated with an increased risk of CAD under the codominant model [GG vs AA; adjusted OR 2.66 (95 % CI, 1.19-5.94), p = .017] and under the recessive model [GG vs AG + AA; adjusted OR 2.10 (95 % CI, 1.10-4.02), p = .025]. The rs2576178 polymorphism did not influence the risk of CAD.

Conclusion: The study suggested for the first time that the rs10887800 renalase gene polymorphism may be involved in the pathogenesis of CAD in hemodialyzed patients and thus could be considered a new genetic risk factor for CAD in this population.

Citing Articles

Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis.

Ganekal P, Vastrad B, Vastrad C, Kotrashetti S Ther Adv Cardiovasc Dis. 2023; 17:17539447231168471.

PMID: 37092838 PMC: 10134165. DOI: 10.1177/17539447231168471.

The Discriminatory Ability of Renalase and Biomarkers of Cardiac Remodeling for the Prediction of Ischemia in Chronic Heart Failure Patients With the Regard to the Ejection Fraction.

Stojanovic D, Mitic V, Stojanovic M, Petrovic D, Ignjatovic A, Milojkovic M Front Cardiovasc Med. 2021; 8:691513.

PMID: 34395559 PMC: 8358392. DOI: 10.3389/fcvm.2021.691513.

Renalase gene Glu37Asp polymorphism affects susceptibility to diabetic retinopathy in type 2 diabetes mellitus.

Buraczynska M, Gwiazda-Tyndel K, Drop B, Zaluska W Acta Diabetol. 2021; 58(12):1595-1602.

PMID: 34156537 PMC: 8542546. DOI: 10.1007/s00592-021-01740-8.

Investigation of Renalase gene rs2576178 polymorphism in patients with coronary artery disease.

Hu N, Wang J, Hu P, Li Z Biosci Rep. 2018; 38(5).

PMID: 30181378 PMC: 6137248. DOI: 10.1042/BSR20180839.

Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients.

Dziedzic M, Powrozek T, Orlowska E, Koch W, Kukula-Koch W, Gawel K PLoS One. 2017; 12(6):e0179218.

PMID: 28614373 PMC: 5470705. DOI: 10.1371/journal.pone.0179218.

References

He B, Hao J, Sheng W, Xiang Y, Zhang J, Zhu H . Correlation between plasma renalase level and coronary artery disease. Pak J Med Sci. 2014; 30(5):863-967. PMC: 4163213. DOI: 10.12669/pjms.305.5286. View

Li X, Jiang W, Li L, Huang R, Yang Q, Yang Y . Renalase gene polymorphism in patients with hypertension and concomitant coronary heart disease. Kidney Blood Press Res. 2014; 39(1):9-16. DOI: 10.1159/000355771. View

Baig S, Coats W, Aggarwal K, Alpert M . Assessing cardiovascular disease in the dialysis patient. Adv Perit Dial. 2009; 25:147-54. View

Desir G . Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens. 2008; 17(2):181-5. DOI: 10.1097/MNH.0b013e3282f521ba. View

Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y . Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol. 2003; 42(8):1429-37. DOI: 10.1016/s0735-1097(03)01062-3. View

Stojanovic D, Cvetkovic T, Stojanovic M, Bojanic V, Stefanovic N, Stojanovic I . The assessment of renalase: searching for the best predictor of early renal dysfunction by multivariate modeling in stable renal transplant recipients. Ann Transplant. 2015; 20:186-92. DOI: 10.12659/AOT.892632. View

Li X, Xie Z, Lin M, Huang R, Liang Z, Huang W . Renalase protects the cardiomyocytes of Sprague-Dawley rats against ischemia and reperfusion injury by reducing myocardial cell necrosis and apoptosis. Kidney Blood Press Res. 2015; 40(3):215-22. DOI: 10.1159/000368497. View

Fava C, Montagnana M, Danese E, Sjogren M, Almgren P, Engstrom G . The Renalase Asp37Glu polymorphism is not associated with hypertension and cardiovascular events in an urban-based prospective cohort: the Malmö Diet and cancer study. BMC Med Genet. 2012; 13:57. PMC: 3458972. DOI: 10.1186/1471-2350-13-57. View

Wu Y, Xu J, Velazquez H, Wang P, Li G, Liu D . Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 2010; 79(8):853-60. DOI: 10.1038/ki.2010.488. View

10.

Hakeem A, Bhatti S, Chang S . Screening and risk stratification of coronary artery disease in end-stage renal disease. JACC Cardiovasc Imaging. 2014; 7(7):715-28. DOI: 10.1016/j.jcmg.2013.12.015. View

11.

Madisen L, Hoar D, Holroyd C, Crisp M, Hodes M . DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet. 1987; 27(2):379-90. DOI: 10.1002/ajmg.1320270216. View

12.

Wang F, Xing T, Li J, Bai M, Hu R, Zhao Z . Renalase's expression and distribution in renal tissue and cells. PLoS One. 2012; 7(10):e46442. PMC: 3463591. DOI: 10.1371/journal.pone.0046442. View

13.

Zhou M, Ma C, Liu W, Liu H, Wang N, Kang Q . Valsartan Promoting Atherosclerotic Plaque Stabilization by Upregulating Renalase: A Potential-Related Gene of Atherosclerosis. J Cardiovasc Pharmacol Ther. 2015; 20(5):509-19. DOI: 10.1177/1074248415575967. View

14.

Buraczynska M, Zukowski P, Buraczynska K, Mozul S, Ksiazek A . Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med. 2011; 13(4):321-7. PMC: 3220827. DOI: 10.1007/s12017-011-8158-6. View

15.

Preuss M, Konig I, Thompson J, Erdmann J, Absher D, Assimes T . Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet. 2010; 3(5):475-83. PMC: 3070269. DOI: 10.1161/CIRCGENETICS.109.899443. View

16.

Collins A . Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003; 325(4):163-7. DOI: 10.1097/00000441-200304000-00002. View

17.

Stec A, Semczuk A, Furmaga J, Ksiazek A, Buraczynska M . Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transplant. 2011; 27(11):4162-6. DOI: 10.1093/ndt/gfr293. View

18.

Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y . Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest. 2005; 115(5):1275-80. PMC: 1074681. DOI: 10.1172/JCI24066. View

19.

Farzaneh-Far R, Desir G, Na B, Schiller N, Whooley M . A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One. 2010; 5(10):e13496. PMC: 2958117. DOI: 10.1371/journal.pone.0013496. View

20.

Zhao Q, Fan Z, He J, Chen S, Li H, Zhang P . Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med (Berl). 2007; 85(8):877-85. DOI: 10.1007/s00109-006-0151-4. View